Investing Women Angels — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Carcinotechcarcinotech.cominJan 2024
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateMaven Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.